Regen BioPharma Inc. announced today successful closing of a transaction resulting in acquisition of issued US patent #8,263,571, and associated preclinical data package. The intellectual property covers specific therapeutic agents that gene silence CTCFL.
http://ift.tt/1EStLYr
http://ift.tt/1EStLYr
No comments:
Post a Comment